Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2025 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2025 Earnings Call Transcript May 7, 2025

Amphastar Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.74, expectations were $0.66.

Operator: Greetings and welcome to the Amphastar Pharmaceuticals First Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that, certain statements made during this...